Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 598 entries
Sorted by: Best Match Show Resources per page
PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23.

Pharmacoepidemiology and drug safety

[No authors listed]
PMID: 26075570
Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):O15-O44. doi: 10.1002/pds.3812. Epub 2015 Jun 15.

No abstract available.

Cite
PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23. Pharmacoepidemiol Drug Saf. 2015;27(7):O15-O44doi: 10.1002/pds.3812.
(2018). PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23. Pharmacoepidemiology and drug safety, 27(7), O15-O44. https://doi.org/10.1002/pds.3812
"PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23." Pharmacoepidemiology and drug safety vol. 27,7 (2018): O15-O44. doi: https://doi.org/10.1002/pds.3812
PRESCRIBING AND RESEARCH IN MEDICINES MANAGEMENT (UK & IRELAND) CONFERENCE 2015 IMPERIAL HOTEL LONDON JANUARY 23. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):O15-O44. doi: 10.1002/pds.3812. Epub 2015 Jun 15. PMID: 26075570.
Copy Download .nbib Format: NLM
Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 "Ethics, Economics and the Future of Medicines - A Population Perspective".

Pharmacoepidemiology and drug safety

[No authors listed]
PMID: 27173876
Pharmacoepidemiol Drug Saf. 2016 May;25:3-23. doi: 10.1002/pds.4019.

No abstract available.

Cite
Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 "Ethics, Economics and the Future of Medicines - A Population Perspective". Pharmacoepidemiol Drug Saf. 2016;25:3-23doi: 10.1002/pds.4019.
(2016). Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 "Ethics, Economics and the Future of Medicines - A Population Perspective". Pharmacoepidemiology and drug safety, 253-23. https://doi.org/10.1002/pds.4019
"Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 "Ethics, Economics and the Future of Medicines - A Population Perspective"." Pharmacoepidemiology and drug safety vol. 25 (2016): 3-23. doi: https://doi.org/10.1002/pds.4019
Prescribing and Research in Medicines Management (UK & Ireland) Conference 2016 Health Foundation London January 29th 2016 "Ethics, Economics and the Future of Medicines - A Population Perspective". Pharmacoepidemiol Drug Saf. 2016 May;25:3-23. doi: 10.1002/pds.4019. PMID: 27173876.
Copy Download .nbib Format: NLM
Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure.

Pharmacoepidemiology and drug safety

Chan TY.
PMID: 15088278
Pharmacoepidemiol Drug Saf. 1996 Jan;5(1):53-4. doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G.

No abstract available.

Cite
Chan TY. Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiol Drug Saf. 1996;5(1):53-4doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G.
Chan, T. Y. (1996). Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiology and drug safety, 5(1), 53-4. https://doi.org/10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G
Chan, T Y. "Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure." Pharmacoepidemiology and drug safety vol. 5,1 (1996): 53-4. doi: https://doi.org/10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G
Chan TY. Recognizing increased sensitivity to warfarin in liver dysfunction secondary to congestive heart failure. Pharmacoepidemiol Drug Saf. 1996 Jan;5(1):53-4. doi: 10.1002/(SICI)1099-1557(199601)5:1<53::AID-PDS209>3.0.CO;2-G. PMID: 15088278.
Copy Download .nbib Format: NLM
Drug use and acute leukemia.

Pharmacoepidemiology and drug safety

Traversa G, Menniti-Ippolito F, Da Cas R, Mele A, Pulsoni A, Mandelli F.
PMID: 15073735
Pharmacoepidemiol Drug Saf. 1998 Mar;7(2):113-23. doi: 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9.

OBJECTIVE: To study the occurrence of acute leukemia in relation to preceding use of drugs a case-control study has been carried out in Rome, Italy.PATIENTS AND METHODS: Two hundred and two patients (age >15 years) with a diagnosis of...

Cite
Traversa G, Menniti-Ippolito F, Da Cas R, et al. Drug use and acute leukemia. Pharmacoepidemiol Drug Saf. 1998;7(2):113-23doi: 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9.
Traversa, G., Menniti-Ippolito, F., Da Cas, R., Mele, A., Pulsoni, A., & Mandelli, F. (1998). Drug use and acute leukemia. Pharmacoepidemiology and drug safety, 7(2), 113-23. https://doi.org/10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9
Traversa, G, et al. "Drug use and acute leukemia." Pharmacoepidemiology and drug safety vol. 7,2 (1998): 113-23. doi: https://doi.org/10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9
Traversa G, Menniti-Ippolito F, Da Cas R, Mele A, Pulsoni A, Mandelli F. Drug use and acute leukemia. Pharmacoepidemiol Drug Saf. 1998 Mar;7(2):113-23. doi: 10.1002/(SICI)1099-1557(199803/04)7:2<113::AID-PDS329>3.0.CO;2-9. PMID: 15073735.
Copy Download .nbib Format: NLM
Prescription patterns of recently graduated physicians in Colombia: a survey during the mandatory social work period.

Pharmacoepidemiology and drug safety

Dennis RJ, Lozano JM, Ruiz JG, Rodriguez MN, Londoño D, Ruiz A.
PMID: 15073742
Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):15-21. doi: 10.1002/(SICI)1099-1557(199801/02)7:1<15::AID-PDS312>3.0.CO;2-O.

MAIN OBJECTIVE: To quantify prescribing patterns of physicians during their year of social work in health centers of Bogotá, Colombia, for three tracer conditions: acute respiratory infection (ARI), systemic hypertension (SH) and acute diarrhea (AD).DESIGN: Cross-sectional survey.SETTING: Primary Care...

Cite
Dennis RJ, Lozano JM, Ruiz JG, et al. Prescription patterns of recently graduated physicians in Colombia: a survey during the mandatory social work period. Pharmacoepidemiol Drug Saf. 1998;7(1):15-21doi: 10.1002/(SICI)1099-1557(199801/02)7:1<15::AID-PDS312>3.0.CO;2-O.
Dennis, R. J., Lozano, J. M., Ruiz, J. G., Rodriguez, M. N., Londoño, D., & Ruiz, A. (1998). Prescription patterns of recently graduated physicians in Colombia: a survey during the mandatory social work period. Pharmacoepidemiology and drug safety, 7(1), 15-21. https://doi.org/10.1002/(SICI)1099-1557(199801/02)7:1<15::AID-PDS312>3.0.CO;2-O
Dennis, R J, et al. "Prescription patterns of recently graduated physicians in Colombia: a survey during the mandatory social work period." Pharmacoepidemiology and drug safety vol. 7,1 (1998): 15-21. doi: https://doi.org/10.1002/(SICI)1099-1557(199801/02)7:1<15::AID-PDS312>3.0.CO;2-O
Dennis RJ, Lozano JM, Ruiz JG, Rodriguez MN, Londoño D, Ruiz A. Prescription patterns of recently graduated physicians in Colombia: a survey during the mandatory social work period. Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):15-21. doi: 10.1002/(SICI)1099-1557(199801/02)7:1<15::AID-PDS312>3.0.CO;2-O. PMID: 15073742.
Copy Download .nbib Format: NLM
Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.

Pharmacoepidemiology and drug safety

[No authors listed]
PMID: 15073745
Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):39-49. doi: 10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z.

This paper is the report of a meeting held in Geneva under the auspices of the Council for International Organizations of Medical Sciences (CIOMS) on 25-26 November 1996. An 11th group of adverse-drug-reaction reporting terms is defined.

Cite
Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders. Pharmacoepidemiol Drug Saf. 1998;7(1):39-49doi: 10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z.
(1998). Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders. Pharmacoepidemiology and drug safety, 7(1), 39-49. https://doi.org/10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z
"Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders." Pharmacoepidemiology and drug safety vol. 7,1 (1998): 39-49. doi: https://doi.org/10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z
Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders. Pharmacoepidemiol Drug Saf. 1998 Jan;7(1):39-49. doi: 10.1002/(SICI)1099-1557(199801/02)7:1<39::AID-PDS316>3.0.CO;2-Z. PMID: 15073745.
Copy Download .nbib Format: NLM
Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission.

Pharmacoepidemiology and drug safety

Goettler M, Schneeweiss S, Hasford J.
PMID: 15073758
Pharmacoepidemiol Drug Saf. 1997 Oct;6:S79-90. doi: 10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f.

Although adverse drug reactions (ADR) are common, there is little knowledge on their direct, indirect and intangible costs. Our study is focused on the direct costs caused by ADR leading to hospital admission. The objective is to quantify the...

Cite
Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf. 1997;6:S79-90doi: 10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f.
Goettler, M., Schneeweiss, S., & Hasford, J. (1997). Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiology and drug safety, 6S79-90. https://doi.org/10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f
Goettler, M, et al. "Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission." Pharmacoepidemiology and drug safety vol. 6 (1997): S79-90. doi: https://doi.org/10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f
Goettler M, Schneeweiss S, Hasford J. Adverse drug reaction monitoring--cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Saf. 1997 Oct;6:S79-90. doi: 10.1002/(sici)1099-1557(199710)6:3+3.3.co;2-f. PMID: 15073758.
Copy Download .nbib Format: NLM
The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996.

Pharmacoepidemiology and drug safety

[No authors listed]
PMID: 15073763
Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):423-8. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<423::AID-PDS285>3.0.CO;2-4.

No abstract available.

Cite
The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996. Pharmacoepidemiol Drug Saf. 1997;6(6):423-8doi: 10.1002/(SICI)1099-1557(199711/12)6:6<423::AID-PDS285>3.0.CO;2-4.
(1997). The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996. Pharmacoepidemiology and drug safety, 6(6), 423-8. https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<423::AID-PDS285>3.0.CO;2-4
"The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996." Pharmacoepidemiology and drug safety vol. 6,6 (1997): 423-8. doi: https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<423::AID-PDS285>3.0.CO;2-4
The effects of NHS reforms on prescribing. Report of the UK Drug Utilisation Research Group regional meeting, Liverpool Medical Institute, Mount Pleasant, Liverpool, Friday 17th May 1996. Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):423-8. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<423::AID-PDS285>3.0.CO;2-4. PMID: 15073763.
Copy Download .nbib Format: NLM
Geriatric prescribing in the medical wards of a teaching hospital in Nepal.

Pharmacoepidemiology and drug safety

Joshi MP, Sugimoto T, Santoso B.
PMID: 15073762
Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):417-21. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J.

A retrospective study on prescribing patterns for 100 randomly selected geriatric patients admitted over a period of 1 year to the medical wards of the Tribhuvan University Teaching Hospital (TUTH) in Nepal showed that polypharmacy was prevalent. During a...

Cite
Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiol Drug Saf. 1997;6(6):417-21doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J.
Joshi, M. P., Sugimoto, T., & Santoso, B. (1997). Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiology and drug safety, 6(6), 417-21. https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J
Joshi, M P, et al. "Geriatric prescribing in the medical wards of a teaching hospital in Nepal." Pharmacoepidemiology and drug safety vol. 6,6 (1997): 417-21. doi: https://doi.org/10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J
Joshi MP, Sugimoto T, Santoso B. Geriatric prescribing in the medical wards of a teaching hospital in Nepal. Pharmacoepidemiol Drug Saf. 1997 Nov;6(6):417-21. doi: 10.1002/(SICI)1099-1557(199711/12)6:6<417::AID-PDS279>3.0.CO;2-J. PMID: 15073762.
Copy Download .nbib Format: NLM
Drug use profile in a Nigerian city hospital.

Pharmacoepidemiology and drug safety

Isah AO, Ohaju-Obodo J, Isah EC, Ozemoya O.
PMID: 15073766
Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):319-24. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U.

The newly introduced WHO Drug Use Indicators enable the delineation of drug use patterns, identification of inappropriate use and evaluation of interventional strategies. This study highlights the drug use pattern in a city hospital and further identifies areas of...

Cite
Isah AO, Ohaju-Obodo J, Isah EC, et al. Drug use profile in a Nigerian city hospital. Pharmacoepidemiol Drug Saf. 1997;6(5):319-24doi: 10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U.
Isah, A. O., Ohaju-Obodo, J., Isah, E. C., & Ozemoya, O. (1997). Drug use profile in a Nigerian city hospital. Pharmacoepidemiology and drug safety, 6(5), 319-24. https://doi.org/10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U
Isah, A O, et al. "Drug use profile in a Nigerian city hospital." Pharmacoepidemiology and drug safety vol. 6,5 (1997): 319-24. doi: https://doi.org/10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U
Isah AO, Ohaju-Obodo J, Isah EC, Ozemoya O. Drug use profile in a Nigerian city hospital. Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):319-24. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<319::AID-PDS307>3.0.CO;2-U. PMID: 15073766.
Copy Download .nbib Format: NLM
Sample size for cohort studies in pharmacoepidemiology.

Pharmacoepidemiology and drug safety

McMahon AD, MacDonald TM.
PMID: 15073768
Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):331-5. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<331::AID-PDS297>3.0.CO;2-9.

OBJECT: Cohort studies in pharmacoepidemiology can result in a unique type of study, where subjects have complex types of exposure to drugs (with periods of non-exposure as well). The object of this paper is to explain how to calculate...

Cite
McMahon AD, MacDonald TM. Sample size for cohort studies in pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 1997;6(5):331-5doi: 10.1002/(SICI)1099-1557(199709/10)6:5<331::AID-PDS297>3.0.CO;2-9.
McMahon, A. D., & MacDonald, T. M. (1997). Sample size for cohort studies in pharmacoepidemiology. Pharmacoepidemiology and drug safety, 6(5), 331-5. https://doi.org/10.1002/(SICI)1099-1557(199709/10)6:5<331::AID-PDS297>3.0.CO;2-9
McMahon, A D, and MacDonald, T M. "Sample size for cohort studies in pharmacoepidemiology." Pharmacoepidemiology and drug safety vol. 6,5 (1997): 331-5. doi: https://doi.org/10.1002/(SICI)1099-1557(199709/10)6:5<331::AID-PDS297>3.0.CO;2-9
McMahon AD, MacDonald TM. Sample size for cohort studies in pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):331-5. doi: 10.1002/(SICI)1099-1557(199709/10)6:5<331::AID-PDS297>3.0.CO;2-9. PMID: 15073768.
Copy Download .nbib Format: NLM
Renal disease and acid-suppressing drugs.

Pharmacoepidemiology and drug safety

García Rodríguez LA, Wallander MA, Johanson S, Björck S.
PMID: 15073775
Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):247-51. doi: 10.1002/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O.

No comparative epidemiological data can be found in the literature on the renal safety of acid-suppressing drugs. We followed-up a cohort of close to 180,000 persons during periods of treatment and non-treatment with five anti-ulcer drugs to evaluate the...

Cite
García Rodríguez LA, Wallander MA, Johanson S, et al. Renal disease and acid-suppressing drugs. Pharmacoepidemiol Drug Saf. 1997;6(4):247-51doi: 10.1002/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O.
García Rodríguez, L. A., Wallander, M. A., Johanson, S., & Björck, S. (1997). Renal disease and acid-suppressing drugs. Pharmacoepidemiology and drug safety, 6(4), 247-51. https://doi.org/10.1002/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O
García Rodríguez, L A, et al. "Renal disease and acid-suppressing drugs." Pharmacoepidemiology and drug safety vol. 6,4 (1997): 247-51. doi: https://doi.org/10.1002/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O
García Rodríguez LA, Wallander MA, Johanson S, Björck S. Renal disease and acid-suppressing drugs. Pharmacoepidemiol Drug Saf. 1997 Jul;6(4):247-51. doi: 10.1002/(SICI)1099-1557(199707)6:4<247::AID-PDS296>3.0.CO;2-O. PMID: 15073775.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 598 entries